These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 23954375)

  • 1. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intertemporal choice in Parkinson's disease.
    Milenkova M; Mohammadi B; Kollewe K; Schrader C; Fellbrich A; Wittfoth M; Dengler R; Münte TF
    Mov Disord; 2011 Sep; 26(11):2004-10. PubMed ID: 21567457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner.
    Cherkasova MV; Corrow JC; Taylor A; Yeung SC; Stubbs JL; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJS
    Parkinsonism Relat Disord; 2019 Sep; 66():189-194. PubMed ID: 31473085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
    Boller JK; Barbe MT; Pauls KA; Reck C; Brand M; Maier F; Fink GR; Timmermann L; Kalbe E
    Exp Neurol; 2014 Apr; 254():70-7. PubMed ID: 24444545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment?
    Somme JH; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    J Neurol Sci; 2014 Oct; 345(1-2):252-3. PubMed ID: 25048409
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control disorders in Parkinson disease: a multicenter case--control study.
    Voon V; Sohr M; Lang AE; Potenza MN; Siderowf AD; Whetteckey J; Weintraub D; Wunderlich GR; Stacy M
    Ann Neurol; 2011 Jun; 69(6):986-96. PubMed ID: 21416496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iowa gambling task in Parkinson's disease.
    Poletti M; Cavedini P; Bonuccelli U
    J Clin Exp Neuropsychol; 2011 Apr; 33(4):395-409. PubMed ID: 21140314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
    Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision making under risk and under ambiguity in Parkinson's disease.
    Delazer M; Sinz H; Zamarian L; Stockner H; Seppi K; Wenning GK; Benke T; Poewe W
    Neuropsychologia; 2009 Jul; 47(8-9):1901-8. PubMed ID: 19428422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.